Evaluation of rationality of drug promotional literature using WHO guidelines in a tertiary care hospital

K. B. Rakesh, Mukta N. Chowta, Vinaykumar Sayeli, Bheemesh Vangalapati, Sunil Pai, Gaurav Tiwary

Research output: Contribution to journalArticle

Abstract

The study was aimed to evaluate the rationality of drug promotional literature using WHO guidelinesThis observational, crosssectional time bound study was conducted at a tertiary care hospital, Mangaluru. A total of 750 drug promotional literature collected over a period of 6 months was assessed for rationality using WHO guidelines. Most of the drug promotional literature collected were from CVS, GIT & Chemotherapy. Out of 750 drug promotional literature, 71 (9.5%) followed WHO guidelines. Most of them mentioned indication, dosage form and its strength and description of the product and package but safety information was missing in most of the drug promotional literature. In addition to WHO criteria, Brief Prescribing Information (BPI) was present in 19% of drug promotional literature. Most of the drug promotional literature did not follow WHO guidelines while promoting their products. Description of the product and the package was present in all the drug promotional literature which give a hint towards their commercial interest.

Original languageEnglish
Article number24
Pages (from-to)139-142
Number of pages4
JournalInternational Journal of Pharmaceutical Sciences Review and Research
Volume36
Issue number2
Publication statusPublished - 01-01-2016

Fingerprint

Drug Evaluation
Tertiary Healthcare
Tertiary Care Centers
Guidelines
Pharmaceutical Preparations
Dosage Forms
Safety
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Rakesh, K. B. ; Chowta, Mukta N. ; Sayeli, Vinaykumar ; Vangalapati, Bheemesh ; Pai, Sunil ; Tiwary, Gaurav. / Evaluation of rationality of drug promotional literature using WHO guidelines in a tertiary care hospital. In: International Journal of Pharmaceutical Sciences Review and Research. 2016 ; Vol. 36, No. 2. pp. 139-142.
@article{1c678e0a242941e6829eae2f13a826e9,
title = "Evaluation of rationality of drug promotional literature using WHO guidelines in a tertiary care hospital",
abstract = "The study was aimed to evaluate the rationality of drug promotional literature using WHO guidelinesThis observational, crosssectional time bound study was conducted at a tertiary care hospital, Mangaluru. A total of 750 drug promotional literature collected over a period of 6 months was assessed for rationality using WHO guidelines. Most of the drug promotional literature collected were from CVS, GIT & Chemotherapy. Out of 750 drug promotional literature, 71 (9.5{\%}) followed WHO guidelines. Most of them mentioned indication, dosage form and its strength and description of the product and package but safety information was missing in most of the drug promotional literature. In addition to WHO criteria, Brief Prescribing Information (BPI) was present in 19{\%} of drug promotional literature. Most of the drug promotional literature did not follow WHO guidelines while promoting their products. Description of the product and the package was present in all the drug promotional literature which give a hint towards their commercial interest.",
author = "Rakesh, {K. B.} and Chowta, {Mukta N.} and Vinaykumar Sayeli and Bheemesh Vangalapati and Sunil Pai and Gaurav Tiwary",
year = "2016",
month = "1",
day = "1",
language = "English",
volume = "36",
pages = "139--142",
journal = "International Journal of Pharmaceutical Sciences Review and Research",
issn = "0976-044X",
publisher = "Global Research Online",
number = "2",

}

Evaluation of rationality of drug promotional literature using WHO guidelines in a tertiary care hospital. / Rakesh, K. B.; Chowta, Mukta N.; Sayeli, Vinaykumar; Vangalapati, Bheemesh; Pai, Sunil; Tiwary, Gaurav.

In: International Journal of Pharmaceutical Sciences Review and Research, Vol. 36, No. 2, 24, 01.01.2016, p. 139-142.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of rationality of drug promotional literature using WHO guidelines in a tertiary care hospital

AU - Rakesh, K. B.

AU - Chowta, Mukta N.

AU - Sayeli, Vinaykumar

AU - Vangalapati, Bheemesh

AU - Pai, Sunil

AU - Tiwary, Gaurav

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The study was aimed to evaluate the rationality of drug promotional literature using WHO guidelinesThis observational, crosssectional time bound study was conducted at a tertiary care hospital, Mangaluru. A total of 750 drug promotional literature collected over a period of 6 months was assessed for rationality using WHO guidelines. Most of the drug promotional literature collected were from CVS, GIT & Chemotherapy. Out of 750 drug promotional literature, 71 (9.5%) followed WHO guidelines. Most of them mentioned indication, dosage form and its strength and description of the product and package but safety information was missing in most of the drug promotional literature. In addition to WHO criteria, Brief Prescribing Information (BPI) was present in 19% of drug promotional literature. Most of the drug promotional literature did not follow WHO guidelines while promoting their products. Description of the product and the package was present in all the drug promotional literature which give a hint towards their commercial interest.

AB - The study was aimed to evaluate the rationality of drug promotional literature using WHO guidelinesThis observational, crosssectional time bound study was conducted at a tertiary care hospital, Mangaluru. A total of 750 drug promotional literature collected over a period of 6 months was assessed for rationality using WHO guidelines. Most of the drug promotional literature collected were from CVS, GIT & Chemotherapy. Out of 750 drug promotional literature, 71 (9.5%) followed WHO guidelines. Most of them mentioned indication, dosage form and its strength and description of the product and package but safety information was missing in most of the drug promotional literature. In addition to WHO criteria, Brief Prescribing Information (BPI) was present in 19% of drug promotional literature. Most of the drug promotional literature did not follow WHO guidelines while promoting their products. Description of the product and the package was present in all the drug promotional literature which give a hint towards their commercial interest.

UR - http://www.scopus.com/inward/record.url?scp=84959363138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959363138&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84959363138

VL - 36

SP - 139

EP - 142

JO - International Journal of Pharmaceutical Sciences Review and Research

JF - International Journal of Pharmaceutical Sciences Review and Research

SN - 0976-044X

IS - 2

M1 - 24

ER -